Log In
BCIQ
Print this Print this
 

rAd26 HIV vaccine

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionHIV vaccine delivered via recombinant adenovirus serotype 26 (rAd26) vector
Molecular Target HIV antigens
Mechanism of ActionVaccine
Therapeutic ModalityGene therapy: Viral vector
Latest Stage of DevelopmentPhase I
Standard IndicationHIV / AIDS
Indication DetailsPrevent HIV
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/03/2009

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today